A detailed history of Dynamic Technology Lab Private LTD transactions in Sage Therapeutics, Inc. stock. As of the latest transaction made, Dynamic Technology Lab Private LTD holds 28,549 shares of SAGE stock, worth $163,585. This represents 0.02% of its overall portfolio holdings.

Number of Shares
28,549
Previous 14,209 100.92%
Holding current value
$163,585
Previous $154,000 33.12%
% of portfolio
0.02%
Previous 0.02%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$7.02 - $13.08 $100,666 - $187,567
14,340 Added 100.92%
28,549 $205,000
Q2 2024

Aug 14, 2024

SELL
$10.58 - $17.9 $209,208 - $353,954
-19,774 Reduced 58.19%
14,209 $154,000
Q1 2024

May 14, 2024

BUY
$18.62 - $26.95 $151,231 - $218,887
8,122 Added 31.41%
33,983 $637,000
Q4 2023

Feb 09, 2024

BUY
$17.1 - $22.26 $442,223 - $575,665
25,861 New
25,861 $560,000
Q2 2023

Aug 14, 2023

SELL
$40.65 - $59.54 $152,681 - $223,632
-3,756 Reduced 25.25%
11,120 $523,000
Q1 2023

May 12, 2023

BUY
$37.27 - $46.57 $554,428 - $692,775
14,876 New
14,876 $624,000
Q2 2022

Aug 12, 2022

BUY
$27.52 - $37.99 $459,033 - $633,673
16,680 New
16,680 $539,000
Q2 2021

Aug 13, 2021

SELL
$54.88 - $79.29 $255,631 - $369,332
-4,658 Closed
0 $0
Q1 2021

May 14, 2021

BUY
$70.65 - $96.76 $329,087 - $450,708
4,658 New
4,658 $349,000
Q2 2020

Aug 14, 2020

SELL
$25.95 - $43.15 $302,213 - $502,524
-11,646 Closed
0 $0
Q1 2020

May 13, 2020

BUY
$26.15 - $77.24 $304,542 - $899,537
11,646 New
11,646 $334,000
Q4 2019

Feb 14, 2020

SELL
$60.18 - $154.77 $133,719 - $343,898
-2,222 Closed
0 $0
Q3 2019

Nov 14, 2019

BUY
$140.29 - $189.96 $94,555 - $128,033
674 Added 43.54%
2,222 $312,000
Q2 2019

Aug 14, 2019

BUY
$157.85 - $183.09 $244,351 - $283,423
1,548 New
1,548 $283,000
Q4 2018

Feb 13, 2019

SELL
$81.94 - $139.71 $703,618 - $1.2 Million
-8,587 Closed
0 $0
Q3 2018

Nov 14, 2018

BUY
$138.11 - $169.04 $1.19 Million - $1.45 Million
8,587 New
8,587 $1.21 Million
Q1 2018

May 14, 2018

SELL
$152.15 - $192.33 $655,157 - $828,172
-4,306 Closed
0 $0
Q4 2017

Feb 09, 2018

BUY
$60.72 - $167.34 $261,460 - $720,566
4,306 New
4,306 $710,000
Q3 2017

Nov 08, 2017

SELL
$61.4 - $88.52 $461,298 - $665,050
-7,513 Closed
0 $0
Q2 2017

Aug 17, 2017

BUY
N/A
7,513
7,513 $598,000

Others Institutions Holding SAGE

About Sage Therapeutics, Inc.


  • Ticker SAGE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 59,422,300
  • Market Cap $340M
  • Description
  • Sage Therapeutics, Inc., a biopharmaceutical company, develops and commercializes medicines to treat central nervous system disorders. Its lead product candidate is ZULRESSO, an intravenous formulation of brexanolone for the treatment of postpartum depression (PPD) in adults. The company's product pipeline also includes zuranolone, a neuroactive...
More about SAGE
Track This Portfolio

Track Dynamic Technology Lab Private LTD Portfolio

Follow Dynamic Technology Lab Private LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Dynamic Technology Lab Private LTD, based on Form 13F filings with the SEC.

News

Stay updated on Dynamic Technology Lab Private LTD with notifications on news.